Clinical trial
Endoluminal Radiofrequency Ablation of Tumors Affecting the Bile Ducts
NCT04801719 is registered in ClinicalTrials.gov with Brno University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endoluminal Radiofrequency Ablation of Tumors Affecting the Bile Ducts
- Lead sponsor
- Brno University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 4, 2010
- Completion date
- December 31, 2019
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract cancer, brachytherapy, radiofrequency ablation, stent complication